MB
Mekiri Bio, Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$1Msold at filing
Total offering$2M$1M still open
Investors in the raise1count reported to the SEC
FiledOct 16, 2025first sale Aug 25, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Debbie LinExecutive Officer
Anita DiFazioExecutive Officer
Aaron DiAntonioDirector
Corey McCannDirector
Executive officers, directors and promoters as listed on the Form D.